Left-Ventricular Unloading With Impella During Refractory Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis.

"Drs. Schrage and Garan received funding from Abiomed. Dr. Schrage received funding from Abbott and AstraZeneca. Dr. Westermann received grants for honorary talks from AstraZeneca, Abiomed, Bayer, Boehringer Ingelheim, Edwards, Novartis, and Medtronic. Dr. Gregers received funding from the Odense University Hospital, Rigshospitalet’s Common Research Foundation, Novo Nordisk Foundation, and Beckett Foundation. Dr. Alonso-Fernandez-Gatta received funding from Instituto de Salud Carlos III (CM19/00055). Dr. Garan received funding from NuPulseCV and Maquet; he received support for article research from Abbott. The remaining authors have disclosed that they do not have any potential conflicts of interest."

"Drs. Schrage and Garan received funding from Abiomed. Dr. Schrage received funding from Abbott and AstraZeneca. Dr. Westermann received grants for honorary talks from AstraZeneca, Abiomed, Bayer, Boehringer Ingelheim, Edwards, Novartis, and Medtronic. Dr. Gregers received funding from the Odense University Hospital, Rigshospitalet’s Common Research Foundation, Novo Nordisk Foundation, and Beckett Foundation. Dr. Alonso-Fernandez-Gatta received funding from Instituto de Salud Carlos III (CM19/00055). Dr. Garan received funding from NuPulseCV and Maquet; he received support for article research from Abbott. The remaining authors have disclosed that they do not have any potential conflicts of interest."

"The protocol of this study was registered at the PROSPERO registry (identifier: CRD42022339499). The systematic review and meta-analyses were conducted according to the Preferred Reported Items for Systematic Reviews and Meta-Analysis checklist (Supplemental Table 1, http://links.lww.com/CCM/H470) ()."